Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 17 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
14(87.5%)
Phase 4
2(12.5%)
16Total
N/A(14)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT07440797Not ApplicableNot Yet Recruiting

EVALUATION OF THE EFFICACY AND TOLERANCE OF VASHE SOLUTION VERSUS SALINE SOLUTION IN THE TREATMENT OF VENOUS OR MIXED LEG ULCERS PRESENTING INFLAMMATORY SIGNS SUGGESTING HEAVY BACTERIAL LOAD

Role: lead

NCT06899919Not ApplicableRecruiting

Efficacy and Safety of Light Compression System in the Local Treatment of Mixed Leg Ulcers (PROMETHEE Clinical Investigation)

Role: lead

NCT06135987Unknown

Clinical Evaluation in Real Life of TLC-NOSF Dressings in the Local Treatment of Chronic Wounds (DFU and VLU)

Role: lead

NCT05158764Not ApplicableCompleted

Efficacy and Safety of URGOBD001 Compression System

Role: lead

NCT05772507Not ApplicableUnknown

Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION)

Role: lead

NCT04613687Not ApplicableUnknown

Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM)

Role: lead

NCT03126396Not ApplicableCompleted

Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers

Role: lead

NCT04159844Not ApplicableUnknown

Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects

Role: lead

NCT03110796Not ApplicableUnknown

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers

Role: lead

NCT02250729Not ApplicableUnknown

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure

Role: collaborator

NCT03670329Not ApplicableUnknown

Management of Infection Risk in Non-comparative Trial (MINT)

Role: lead

NCT03640871Not ApplicableUnknown

HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer

Role: lead

NCT02583958Not ApplicableUnknown

Assessment of Efficacy & Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers

Role: lead

NCT01717183Not ApplicableUnknown

Assessment of the Efficacy and Safety of a New Wound Dressing in the Local Treatment of Diabetic Foot Ulcers

Role: lead

NCT01449422Phase 4Completed

Clinical Trial to Evaluate the Efficacy, Tolerance and Acceptability of URGO Dressing vs a Hydrofibre in the Local Management of Venous or Predominantly Venous Mixed Leg Ulcers.

Role: lead

NCT01716273Not ApplicableUnknown

Use of White Granulated Sugar on Wounds

Role: collaborator

NCT00770627Phase 4Unknown

Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children

Role: lead

All 17 trials loaded